TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Market News Page 3 of 212 • 5,299 articles
JHX Investor Deadline Alert: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms
GlobeNewswire Inc. • Hagens Berman
JHX Investor Deadline Alert: James Hardie (JHX) Class Action Lawsuit — Hagens Berman Scrutinizing Alleged Inventory Destocking and 34% Plunge; December 23 Lead Plaintiff Deadline Looms

12/16/2025 08:51 PM • James Hardie Industries faces a class action lawsuit alleging executives misled investors about North America segment sales and inventory levels, resulting in a 34% stock price drop in August 2025.

JHX - Accused of concealing weak sales demand, making false statements about inventory levels, and experiencing significant stock price decline after revealing 12% sales drop
#securities lawsuit #inventory destocking #stock drop #misleading statements
Read More
Faraday Future to Deliver an FX Super One to Ras Al Khaimah Innovation City on December 22, Advancing Deliveries in the Middle East
GlobeNewswire Inc. • Faraday Future
Faraday Future to Deliver an FX Super One to Ras Al Khaimah Innovation City on December 22, Advancing Deliveries in the Middle East

12/16/2025 08:47 PM • Faraday Future plans to deliver an FX Super One MPV to Ras Al Khaimah Innovation City on December 22, marking its second vehicle delivery in the UAE. The company operates a regional production center in Ras Al Khaimah and aims to expand its operations and develop a new energy mobility ecosystem.

FFAI - Company is expanding operations, making strategic deliveries, and establishing presence in new markets with planned vehicle production and innovation initiatives
#electric vehicle #MPV #UAE #innovation #delivery
Read More
ALT5 Investor Alert: Hagens Berman Scrutinizing ALT5 Sigma (ALTS) Over Potential Disclosure Violations
GlobeNewswire Inc. • Reed Kathrein
ALT5 Investor Alert: Hagens Berman Scrutinizing ALT5 Sigma (ALTS) Over Potential Disclosure Violations

12/16/2025 08:39 PM • Hagens Berman is investigating ALT5 Sigma for potential financial reporting violations, including delayed disclosures about auditor resignation, CEO suspension, and a subsidiary's criminal judgment for money laundering.

ALTS - Stock dropped 80%, CEO and CFO terminated, Nasdaq non-compliance notice issued, potential financial misstatements, subsidiary convicted of money laundering, auditor resigned, suggesting severe governance and financial reporting failures
#securities fraud #financial reporting #corporate governance #disclosure violations #money laundering
Read More
CPNG Announcement: If You Have Suffered Losses in Coupang, Inc. (NYSE: CPNG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc. • Rosen Law Firm
CPNG Announcement: If You Have Suffered Losses in Coupang, Inc. (NYSE: CPNG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

12/16/2025 07:42 PM • Rosen Law Firm is investigating potential securities claims against Coupang following a massive data breach affecting 34 million users, which led to the resignation of the South Korean unit's head and a 3.2% stock drop.

CPNG - Stock experienced decline due to significant data breach affecting 34 million users, resulting in leadership resignation and potential legal action
#securities claims #data breach #class action #investor losses
Read More
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc. • Joyce Allaire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

12/16/2025 07:31 PM • Annexon, a biopharmaceutical company, granted a stock option to a new non-executive employee for 19,000 shares with a 4-year vesting schedule and an exercise price of $4.91 per share.

ANNX - The article describes a routine stock option grant to a new employee, which is a standard practice for tech and biotech companies and does not indicate significant positive or negative business developments
#stock option #employee compensation #biopharmaceutical #neuroinflammation
Read More
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors
GlobeNewswire Inc. • Hutchmed
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors

12/16/2025 07:00 PM • HUTCHMED launched a global Phase I/IIa clinical trial for HMPL-A251, a novel antibody-targeted therapy conjugate (ATTC) designed to treat HER2-expressing solid tumors with potentially improved safety and efficacy.

HCM - Company is advancing innovative cancer treatment platform with first-in-human trial of a novel therapeutic approach, demonstrating technological innovation and potential clinical progress
#clinical trial #oncology #ATTC #PI3K/PIKK inhibitor #HER2 #targeted therapy
Read More
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
GlobeNewswire Inc. • Hagens Berman
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

12/16/2025 06:54 PM • Telix Pharmaceuticals faces a class action lawsuit alleging misleading statements about drug development and manufacturing capabilities, resulting in a 21% stock drop after receiving an SEC subpoena and FDA Complete Response Letter.

TLX - Company experienced significant stock decline due to alleged regulatory failures, misleading disclosures about drug development progress, and manufacturing compliance issues
#securities class action #SEC subpoena #FDA CRL #manufacturing deficiencies #investor losses
Read More
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating
GlobeNewswire Inc. • Na
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

12/16/2025 06:53 PM • Rezolute's stock dropped 90% after its Phase 3 trial for ersodetug failed to meet primary and secondary endpoints in treating hypoglycemia caused by hyperinsulinism, prompting a shareholder investigation.

RZLT - Stock price crashed 90% due to clinical trial failure, contradicting previous investor assurances about drug efficacy and market potential
#Phase 3 trial #hypoglycemia #ersodetug #stock crash #shareholder investigation
Read More
STUB Investor Alert: Hagens Berman Urges Investors to Act by Jan. 23 Over 143% Free Cash Flow Collapse and Alleged IPO Misrepresentations
GlobeNewswire Inc. • Reed Kathrein
STUB Investor Alert: Hagens Berman Urges Investors to Act by Jan. 23 Over 143% Free Cash Flow Collapse and Alleged IPO Misrepresentations

12/16/2025 06:50 PM • Hagens Berman law firm is investigating StubHub Holdings for alleged securities violations related to their September 2025 IPO, claiming material misstatements in offering documents that concealed adverse vendor payment trends and led to a 143% free cash flow collapse.

STUB - Stock experienced significant market capitalization loss due to alleged financial misrepresentations, with a 143% free cash flow decline and potential legal liability for misleading investors during IPO
#IPO #securities lawsuit #free cash flow #vendor payments #disclosure
Read More
54% STRIDE (LRN) CRASH: Hagens Berman Scrutinizing Stride (LRN) Over Alleged “Ghost Students” Fraud and Concealed Tech Failure
GlobeNewswire Inc. • Reed Kathrein
54% STRIDE (LRN) CRASH: Hagens Berman Scrutinizing Stride (LRN) Over Alleged “Ghost Students” Fraud and Concealed Tech Failure

12/16/2025 06:32 PM • Stride Inc. faces a securities class action lawsuit alleging fraudulent enrollment metrics and a critical technology platform failure that caused a 54% stock crash, with potential investor losses during October 2024-2025.

LRN - Company allegedly inflated enrollment figures using 'Ghost Students', concealed a technology platform failure affecting 10,000-15,000 students, and experienced a dramatic 54% stock price collapse due to disclosed operational issues
#securities fraud #enrollment metrics #technology failure #investor losses #ghost students
Read More
INSPIRE MEDICAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
GlobeNewswire Inc. • Rosen Law Firm
INSPIRE MEDICAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

12/16/2025 06:32 PM • Rosen Law Firm is investigating a potential securities class action against Inspire Medical Systems regarding misrepresentations about their Inspire V sleep apnea device's market demand and launch readiness.

INSP - The lawsuit alleges the company misrepresented key facts about their Inspire V device, potentially misleading investors about market demand and launch preparedness, which suggests potential corporate misconduct
#securities class action #sleep apnea #investor rights #stock lawsuit
Read More
FLY DEADLINE: Firefly Aerospace Inc. Investors Encouraged to Contact Kirby McInerney LLP Before Looming Deadline in Lawsuit
GlobeNewswire Inc. • Kirby Mcinerney Llp
FLY DEADLINE: Firefly Aerospace Inc. Investors Encouraged to Contact Kirby McInerney LLP Before Looming Deadline in Lawsuit

12/16/2025 06:00 PM • Firefly Aerospace is facing a securities fraud class action lawsuit alleging misleading IPO documents, overstated market prospects, and operational challenges with its Alpha rocket program, following significant financial losses and a rocket launch failure.

C - Serving as a joint book-running manager for the offering, which is a standard investment banking service
FLY - Company experienced substantial financial losses, missed revenue estimates, reported significant quarterly losses, had a rocket launch failure, and is now facing a securities fraud lawsuit alleging misrepresentation of its business prospects
#securities fraud #IPO #rocket launch #financial performance #class action lawsuit
Read More
Rocket Lab Schedules Launch for U.S. Space Force’s STP-S30 Mission, Brings Launch Forward By Several Months
GlobeNewswire Inc. • Rocket Lab Corporation
Rocket Lab Schedules Launch for U.S. Space Force’s STP-S30 Mission, Brings Launch Forward By Several Months

12/16/2025 06:00 PM • Rocket Lab will launch the STP-S30 mission for the U.S. Space Force, deploying four innovative disk-shaped spacecraft developed by The Aerospace Corporation, ahead of the original schedule.

JEF - Serving as a joint book-running manager for the offering, which is a standard investment banking service
RKLB - Successfully accelerated launch timeline, demonstrating agility and responsiveness in space launch services
#launch #space force #DiskSats #satellite #space technology
Read More
Medline Announces Pricing of Upsized Initial Public Offering
GlobeNewswire Inc. • Medline Inc.
Medline Announces Pricing of Upsized Initial Public Offering

12/16/2025 06:00 PM • Medline Inc. announced its initial public offering of 216,034,482 Class A common stock shares at $29.00 per share, with plans to use proceeds for debt repayment and corporate purposes. The shares are expected to begin trading on Nasdaq on December 17, 2025.

VYLD - Serving as a joint book-running manager for the offering, which is a standard investment banking service
GS - Serving as a global coordinator and lead bookrunning manager for the IPO, indicating a standard business transaction
#IPO #medical supplies #stock offering #Nasdaq #public trading
Read More
3 Grocery Stocks With Above-Average Dividends, Long-Term Returns
Investing.com • Bob Ciura
3 Grocery Stocks With Above-Average Dividends, Long-Term Returns

12/16/2025 05:54 PM • The article discusses three resilient grocery stocks that offer reliable dividends and have demonstrated strong performance during economic challenges: Kroger, Albertsons, and Dollar General.

CpN - Serving as a joint book-running manager for the offering, which is a standard investment banking service
KR - Strong earnings growth (9-15.3% CAGR), exceptional resilience during economic downturns, healthy balance sheet with $4.9B cash, and consistent performance
#grocery stocks #dividends #retail #recession resilience #earnings
Read More
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
GlobeNewswire Inc. • Hagens Berman
INSP INVESTOR ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

12/16/2025 05:51 PM • Inspire Medical Systems faces a securities class action lawsuit alleging management misled investors about operational readiness for its Inspire V device launch, resulting in significant stock value decline and revenue disruption.

INSP - Stock dropped $42.04 per share (32.4% decline), EPS guidance slashed by over 80%, alleged concealment of critical operational failures including Medicare billing software issues and inventory glut
#securities fraud #medical device #Medicare billing #stock decline #investor lawsuit
Read More
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Declares Year-End Capital Gain Distribution
Benzinga • Prnewswire
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Declares Year-End Capital Gain Distribution

12/16/2025 05:36 PM • Cohen & Steers Quality Income Realty Fund (RQI) announced a year-end capital gain distribution to meet federal excise tax requirements, with a substantial portion of the distribution being taxable to shareholders in 2025.

CNS - The company is presenting standard financial information about its fund's distribution policy without indicating any major changes or concerns
#capital gain distribution #realty fund #tax distribution #investment #real estate
Read More
Stock Market Today, Dec. 16: Comcast Jumps on Activist Investor Speculation
The Motley Fool • Josh Kohn-Lindquist
Stock Market Today, Dec. 16: Comcast Jumps on Activist Investor Speculation

12/16/2025 05:33 PM • Comcast stock surged 5.39% on speculation of activist investor interest and following the record date for its cable television networks spinoff, trading at a low 5x EBITDA multiple.

CCZ - Stock jumped 5.39%, high trading volume, potential activist investor interest, low EBITDA multiple, and named to Barron's Top 10 stocks for 2026
#Comcast #activist investor #spinoff #Versant #EBITDA
Read More
Is Constellation Energy Stock a Buy Now?
The Motley Fool • Reuben Gregg Brewer
Is Constellation Energy Stock a Buy Now?

12/16/2025 05:31 PM • Constellation Energy, a leading independent power producer with significant nuclear power capabilities, is performing well financially but may be overvalued. The company is acquiring Calpine Group and benefits from rising electricity demand, particularly from data centers and electric vehicles.

CEG - Strong business performance and strategic growth potential, but currently overpriced with a high P/E ratio of 40x and low dividend yield of 0.4%. Recommended to keep on a watchlist rather than immediately buying.
#nuclear power #electricity generation #independent power producer #energy stocks #Calpine acquisition
Read More
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc. • Galecto, Inc.
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

12/16/2025 05:00 PM • Galecto's Board of Directors approved granting 312,535 non-qualified stock options to a new employee at an exercise price of $32.00, with a vesting schedule starting from the first anniversary of the grant date.

JPMpJ - Serving as a joint book-running manager for the offering, which is a standard investment banking service
GLTO - The stock option grant is a standard corporate practice for attracting and retaining talent, indicating routine business activity without significant positive or negative implications
#stock options #employee compensation #biotechnology #inducement grant
Read More
Cal-Maine Foods Schedules Second Quarter Fiscal 2026 Earnings Release, Conference Call and Webcast
GlobeNewswire Inc. • Cal-Maine Foods, Inc.
Cal-Maine Foods Schedules Second Quarter Fiscal 2026 Earnings Release, Conference Call and Webcast

12/16/2025 05:00 PM • Cal-Maine Foods, the largest egg company in the United States, will report its fiscal 2026 second quarter results on January 7, 2026, with a conference call and webcast scheduled for 9:00 a.m. ET.

JPMpD - Serving as a joint book-running manager for the offering, which is a standard investment banking service
CALM - The article is a standard earnings announcement with no explicit positive or negative indicators, presenting routine financial reporting information
#earnings #conference call #webcast #egg industry
Read More
Bird Awarded $1.2B Across Industrial and Industrial Maintenance Teams
GlobeNewswire Inc. • T.L. Mckibbon
Bird Awarded $1.2B Across Industrial and Industrial Maintenance Teams

12/16/2025 05:00 PM • Bird Construction has been awarded multiple projects and multi-year service agreements totaling approximately $1.2 billion, including significant industrial maintenance contracts and expansion into new sectors like mid-stream oil and gas.

JPMpC - Serving as a joint book-running manager for the offering, which is a standard investment banking service
BHP - Continuing to invest in significant resource projects like the Jansen potash project, indicating ongoing industrial development
#construction #industrial maintenance #service agreements #potash project #indigenous partnerships
Read More
Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services
GlobeNewswire Inc. • Solid Biosciences Inc.
Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services

12/16/2025 04:51 PM • U.S. Department of Health and Human Services added Duchenne muscular dystrophy to the Recommended Uniform Screening Panel, which is expected to accelerate early detection and improve patient outcomes.

JPMpK - Serving as a joint book-running manager for the offering, which is a standard investment banking service
SLDB - Company is actively supporting Duchenne research, advocating for newborn screening, and developing innovative gene therapy treatments, demonstrating proactive commitment to addressing the disease
#Duchenne muscular dystrophy #newborn screening #gene therapy #rare disease
Read More
The E.W. Scripps Company board determines the Sinclair proposal is not in the best interests of the company and its shareholders
GlobeNewswire Inc. • E.W. Scripps Company
The E.W. Scripps Company board determines the Sinclair proposal is not in the best interests of the company and its shareholders

12/16/2025 04:45 PM • The E.W. Scripps Company board unanimously rejected Sinclair's unsolicited $7 per share acquisition proposal, stating it does not serve the best interests of shareholders or the company.

JPMpL - Serving as a joint book-running manager for the offering, which is a standard investment banking service
SSP - Rejected the proposal but remains open to future value-enhancing opportunities
#acquisition #merger #board rejection #shareholder rights
Read More
Warner Bros To Advise Shareholders Reject Paramount, Accept Netflix Offer: Report
Benzinga • Erica Kollmann
Warner Bros To Advise Shareholders Reject Paramount, Accept Netflix Offer: Report

12/16/2025 04:36 PM • Warner Bros. Discovery plans to recommend shareholders reject Paramount Skydance's takeover bid and instead accept Netflix's offer of $27.75 per share for its HBO Max streaming division.

JPMpM - Serving as a joint book-running manager for the offering, which is a standard investment banking service
WBD - Actively managing potential acquisition offers and strategically evaluating options
#merger #acquisition #streaming #media #shareholders
Read More